SCHEMBL27828482

SCHEMBL27828482

CCC(CC)(CO)CCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 1/20 0.48
THRB P10828 1/20 0.48
FFAR3 O14843 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
NAALAD2 Q9Y3Q0 1/20 0.38
AKR1B1 P15121 1/20 0.37
LMNA P02545 2/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
GPR84 Q9NQS5 7/20 0.36
PPARG P37231 7/20 0.36
PPARD Q03181 7/20 0.36
PPARA Q07869 7/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511759 0.87 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL8764214 0.87 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ACYP1A2THRB
Succinic Acid SCHEMBL542105 0.85 LMNA (0.47) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL5138772 0.85 LMNA (0.44) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL31130665 0.85 LMNA (0.44) ALDH1A1MEN1KMT2ACYP1A2THRB
SCHEMBL7192372 0.82 AKR1B1 (0.44) ALDH1A1MEN1KMT2ACYP1A2THRB
Adipic Acid SCHEMBL536473 0.81 AKR1B1 (0.54) ALDH1A1MEN1KMT2AAKR1B1LMNA
Adipic Acid SCHEMBL536569 0.81 AKR1B1 (0.54) ALDH1A1MEN1KMT2AAKR1B1LMNA
Adipic Acid SCHEMBL7761237 0.81 AKR1B1 (0.54) ALDH1A1MEN1KMT2AAKR1B1LMNA
Butyric Acid SCHEMBL813982 0.81 FFAR3 (0.62) ALDH1A1MEN1KMT2ACYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910150-B 4-benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis NOVARTIS AG 2013-09-18 CN disclosed
CN-101910150-A 4-benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis NOVARTIS AG 2010-12-08 CN disclosed